UFA
RDY icon

US Financial Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

US Financial Advisors’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-105
Closed -$1K – 319
2016
Q1 		$1K Hold
105
– – ﹤0.01% 414
2015
Q4 		$1K Hold
105
– – ﹤0.01% 554
2015
Q3 		$1K Hold
105
– – ﹤0.01% 509
2015
Q2 		$1K Buy
+105
New +$1.16K ﹤0.01% 472

Other funds holding RDY

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

US Financial Advisors's RDY Position: Q2 2016 in Review

US Financial Advisors sold out of Dr. Reddy's Laboratories (RDY) in Q2 2016, closing a stake of 105 shares — an estimated $1K sold.

US Financial Advisors first reported a position in RDY in Q2 2015 and held it in 4 quarters. The position peaked at $1K in Q1 2016. 157 funds tracked by Wall St. Rank hold RDY as of Q2 2016.

  • US Financial Advisors reported no remaining Dr. Reddy's Laboratories position as of Q2 2016 after selling out during the quarter.
  • US Financial Advisors sold 105 Dr. Reddy's Laboratories shares in Q2 2016, an estimated $1K.
  • US Financial Advisors first reported a position in Dr. Reddy's Laboratories in Q2 2015 and held it in 4 quarters.
  • US Financial Advisors's Dr. Reddy's Laboratories position peaked at $1K in Q1 2016.
  • 157 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2016.

Based on US Financial Advisors's 13F filing for Q2 2016, filed 12 Aug 2016.